PMID- 31878994 OWN - NLM STAT- MEDLINE DCOM- 20200116 LR - 20211204 IS - 1007-8738 (Print) IS - 1007-8738 (Linking) VI - 35 IP - 11 DP - 2019 Nov TI - [TP53BP2/ASPP2 inhibits autophagy of HepG2 cells by activating mTOR pathway in a p53-independent manner]. PG - 986-991 AB - Objective To study the regulative effect of tumor protein p53 binding protein 2/p53 apoptosis-stimulating protein 2 (TP53BP2/ASPP2) on the autophagy of HepG2 human hepatoma cells and its mechanism. Methods The expression of ASPP2 was up-regulated or down-regulated by HepG2 cells infected with adenovirus and lentivirus. HepG2 cells were cultured in medium without fetal bovine serum for 24 hours. Western blotting was used to detect the expression of microtubule-associated protein 1 light chain 3 (LC3), beclin1, P62, autophagy-related gene 5 (ATG5), ATG7, and mammalian target of rapamycin (mTOR) pathway-associated protein mTOR, phospho-mTOR (p-mTOR), eukaryotic transcription initiation factor 4E binding protein 1 (4EBP1), phospho-4EBP1 (p-4EBP1), ribosomal protein S6, phospho-S6 (p-S6), ribosomal S6 kinase B1 (RPS6KB1/p70S6K), phospho-p70S6K (p-p70S6K). Fluorescence microscopy was used to detect the green fluorescent protein-microtubule-associated protein 1 light chain 3 (GFP-LC3) fusion protein expressed by the cells. At the same time, the Hep3B cells without p53 expression were infected with lentivirus, and the levels of ASPP2 in the cells were knocked down. Western blotting was performed to detect the expression of ASPP2 and mTOR pathway-associated protein mTOR, p-mTOR, 4EBP1, p-4EBP1, S6, p-S6, RPS6KB1/p70S6K, p-p70S6K. Results When the expression of ASPP2 was up-regulated, the mTOR complex 1 (mTORC1) pathway was activated, and the expression of autophagy-related proteins and the number of autophagosomes were reduced. After the expression of ASPP2 was down-regulated, the mTORC1 pathway was inhibited, and the expression level of autophagy-related proteins and the number of autophagosomes increased. In Hep3B cells with p53 expression silence, the mTORC1 pathway was still inhibited when ASPP2 wasdown-regulated. Conclusion ASPP2 inhibits the autophagy of HepG2 cells by activating mTOR pathway in a p53-independent manner. FAU - Xu, Ping AU - Xu P AD - Beijing Institute of Hepatology, Beijing Youan Hospital, Beijing Engineering Research Center for Precision Medicine and Transformation of Hepatitis and Liver Cancer, Capital Medical University, Beijing 100069, China. FAU - Shi, Honglin AU - Shi H AD - Beijing Institute of Hepatology, Beijing Youan Hospital, Beijing Engineering Research Center for Precision Medicine and Transformation of Hepatitis and Liver Cancer, Capital Medical University, Beijing 100069, China. FAU - Jiao, Yan AU - Jiao Y AD - Beijing Institute of Hepatology, Beijing Youan Hospital, Beijing Engineering Research Center for Precision Medicine and Transformation of Hepatitis and Liver Cancer, Capital Medical University, Beijing 100069, China. FAU - Chen, Dexi AU - Chen D AD - Beijing Institute of Hepatology, Beijing Youan Hospital, Beijing Engineering Research Center for Precision Medicine and Transformation of Hepatitis and Liver Cancer, Capital Medical University, Beijing 100069, China. FAU - Shi, Hongbo AU - Shi H AD - Beijing Institute of Hepatology, Beijing Youan Hospital, Beijing Engineering Research Center for Precision Medicine and Transformation of Hepatitis and Liver Cancer, Capital Medical University, Beijing 100069, China. *Corresponding author, E-mail: shb411@126.com. LA - chi PT - Journal Article PL - China TA - Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi JT - Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology JID - 101139110 RN - 0 (Apoptosis Regulatory Proteins) RN - 0 (TP53BP2 protein, human) RN - 0 (Tumor Suppressor Protein p53) RN - EC 2.7.1.1 (MTOR protein, human) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) SB - IM MH - Apoptosis Regulatory Proteins/*metabolism MH - *Autophagy MH - Hep G2 Cells MH - Humans MH - *Signal Transduction MH - TOR Serine-Threonine Kinases/*metabolism MH - Tumor Suppressor Protein p53 EDAT- 2019/12/28 06:00 MHDA- 2020/01/17 06:00 CRDT- 2019/12/28 06:00 PHST- 2019/12/28 06:00 [entrez] PHST- 2019/12/28 06:00 [pubmed] PHST- 2020/01/17 06:00 [medline] PST - ppublish SO - Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2019 Nov;35(11):986-991.